Risk Factors and Opportunities for Prevention of Early-onset Neonatal Sepsis: A Multicenter Case-Control Study

Author:

Schuchat Anne1,Zywicki Sara S.1,Dinsmoor Mara J.2,Mercer Brian3,Romaguera Josefina4,O'Sullivan Mary Jo5,Patel Daksha6,Peters Mark T.7,Stoll Barbara8,Levine Orin S.1,

Affiliation:

1. From the Centers for Disease Control and Prevention, Atlanta, Georgia;

2. Medical College of Virginia of Virginia Commonwealth University, Richmond, Virginia;

3. University of Tennessee at Memphis, Regional Medical Center, Memphis, Tennessee;

4. University of Puerto Rico, San Juan, Puerto Rico;

5. University of Miami Medical Center–Jackson Memorial Hospital, Miami, Florida;

6. University of Mississippi Medical Center, Jackson, Mississippi;

7. Broward General Medical Center, Fort Lauderdale, Florida; and the

8. Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia.

Abstract

Background. Early-onset group B streptococcal (GBS) prevention efforts are based on targeted use of intrapartum antibiotic prophylaxis (IAP); applicability of these prevention efforts to infections caused by other organisms is not clear. Methods. Multicenter surveillance during 1995 to 1996 for culture-confirmed, early-onset sepsis in an aggregate of 52 406 births; matched case-control study of risk factors for GBS and other sepsis. Results. Early-onset disease occurred in 188 infants (3.5 cases per 1000 live births). GBS (1.4 cases per 1000 births) andEscherichia coli (0.6 cases per 1000 births) caused most infections. GBS sepsis less often occurred in preterm deliveries compared with other sepsis. Compared with gestation-matched controls without documented sepsis, GBS disease was associated with intrapartum fever (matched OR, 4.1; CI, 1.2–13.4) and frequent vaginal exams (matched OR, 2.9; CI, 1.1–8.0). An obstetric risk factor—preterm delivery, intrapartum fever, or membrane rupture ≥18 hours—was found in 49% of GBS cases and 79% of other sepsis. IAP had an adjusted efficacy of 68.2% against any early-onset sepsis. Ampicillin resistance was evident in 69% of E coliinfections. No deaths occurred among susceptible E coliinfections, whereas 41% of ampicillin-resistant E coliinfections were fatal. Ninety-one percent of infants who developed ampicillin-resistant E coli infections were preterm, and 59% of these infants were born to mothers who had received IAP. Conclusions. Either prenatal GBS screening or a risk-based strategy could potentially prevent a substantial portion of GBS cases. Sepsis caused by other organisms is more often a disease of prematurity. IAP seemed efficacious against early-onset sepsis. However, the severity of ampicillin-resistant E colisepsis and its occurrence after maternal antibiotics suggest caution regarding use of ampicillin instead of penicillin for GBS prophylaxis.

Publisher

American Academy of Pediatrics (AAP)

Subject

Pediatrics, Perinatology, and Child Health

Reference20 articles.

1. Epidemiology of group B streptococcal disease: risk factors, prevention strategies and vaccine development.;Schuchat;Epidemiol Rev.,1994

2. Prevention of early-onset neonatal group B streptococcal disease with selective intrapartum chemoprophylaxis.;Boyer;N Engl J Med.,1986

3. Group B streptococcus and neonatal infections: the case for intrapartum chemoprophylaxis.;Garland;Aust N Z J Obstet Gynaecol.,1991

4. Prevention of perinatal group B streptococcal disease: a public health perspective.;Schuchat;MMWR Morb Mortal Wkly Rep.,1996

5. Neonatal early-onset Escherichia coli disease: the effect of intrapartum ampicillin.;Joseph;Arch Pediatr Adolesc Med.,1998

Cited by 258 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3